Trials / Unknown
UnknownNCT02576262
HPV Integration Testing for Human Papillomavirus-Positive Women
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- Female
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Papanicolaou (Pap) triage, with high specificity, has been recommended for primary Human papillomavirus (HPV) testing but is flawed by poor sensitivity and cytologist dependence. the investigators evaluated the potential role of HPV Integration detection in cervical exfoliated cells in HPV-positive women from a clinic-based population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TCT，HPV，colposcopic inspection |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2018-09-01
- Completion
- 2020-09-01
- First posted
- 2015-10-15
- Last updated
- 2017-06-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02576262. Inclusion in this directory is not an endorsement.